Lithuania's new assessment procedure for reimbursable medicines: will there be any positive changes?

15 May 2019

Lithuanian attorney Ruta Pumputiene provides an Expert View on amendments to the Lithuanian Pharmaceutical Law and the subsequent changes to the reimbursable medicines system.

The Spring Session Agenda of Seimas, the parliament of Lithuania, includes long-promised changes, namely amendments to the Pharmaceutical Law, which will legitimize the system of inclusion of medicines in the reimbursable medicines’ lists.

After adopting the amendments at Parliament, the Minister of Health will still have to adopt a new order which would detail this new system. The manufacturers, doctors, and patients are waiting for it eagerly. It is not clear yet whether the new procedure will complicate and damage Lithuanian patients’ access to the newest and most effective medicines.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK